Clinical Interest of the Temporary Urethral Stent Allium " Bulbar Urethral Stent " in the Treatment of Detrusor Sphincter Dyssynergia
Launched by HOSPICES CIVILS DE LYON · Dec 17, 2014
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male patient aged more than 18 years old
- • Presenting detrusor striated sphincter dyssynergia in the opinion of the investigator, based on clinical data and proven urodynamically
- • Detrusor striated sphincter dyssynergia with identified neurological origin
- • With contraindication or failure of the conventional treatments
- • Accepting the principle of the prosthetic incontinentation
- • Having given his signed consent to participate in the study
- • Affiliated with a social security scheme or assimilated.
- Exclusion Criteria:
- • Minor patient or protected adult according to the terms of the law
- • Presenting contraindications to local regional anaesthesia
- • Presenting contraindications or a previous failure to the treatment by prosthetic sphincterotomy
- • Unable to hold a penile sheath.
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pierre Bénite Cedex, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials